Inositol pyrophosphates, and methods of use thereof
The present invention comprises compounds, compositions thereof, and methods capable of delivering modified inositol hexaphospahte (IHP) comprising an internal pyrophosphate ring to the cytoplasm of mammalian cells. In certain embodiments, the present invention relates to compounds, compositions thereof, and methods that enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells.
1. A method of treating a mammal afflicted with diabetes, comprising the step of administering to said mammal a therapeutically effective amount of a composition comprising a compound represented by structure I:
nC + A n− (I)
wherein:
C + represents independently for each occurrence an aliphatic ammonium cation, an alkali metal cation, an alkaline metal cation, or other suitable metal cation; and
A represents an anionic ligand for a mammalian cellular receptor, wherein said anionic ligand comprises 1, 2, or 3 pyrophosphate rings; and
n is an integer in the range of 1 to 10 inclusive.
2. The method of claim 1 , wherein A is represented by the compound of structure II:
3. The method of claim 2 , wherein C is sodium and n is 6.
4. The method of claim 2 , wherein the compound is administered orally.
5. The method of claim 2 , wherein C is alkaline metal cation.
6. The method of claim 2 , wherein the alkaline metal cation is calcium.